These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6492217)

  • 1. [Effect of azosemide (SK-110) and its metabolites on mouse liver].
    Asaeda N; Ikawa E; Tamano S; Tagawa Y; Shinoda M; Haruyama K; Koide M
    J Toxicol Sci; 1984 Jun; 9 Suppl 1():89-108. PubMed ID: 6492217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of diuretic, azosemide (SK-110), in combination with antibiotic, cephaloridine, on kidney].
    Asaeda N; Shinoda M; Tamano S; Ikawa E; Yoshiyasu T; Iwai H; Nagai N; Tagawa Y; Koide M
    J Toxicol Sci; 1984 Jun; 9 Suppl 1():73-88. PubMed ID: 6492216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of diuretic effects and changes in plasma aldosterone concentration following oral administration of a single dose of furosemide or azosemide in healthy dogs.
    Hori Y; Katou A; Tsubaki M; Kanai K; Nakao R; Hoshi F; Itoh N; Higuchi S
    Am J Vet Res; 2008 Dec; 69(12):1664-9. PubMed ID: 19046016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between hepatotoxicity and induction of replicative DNA synthesis following single or multiple doses of carbon tetrachloride.
    Doolittle DJ; Muller G; Scribner HE
    J Toxicol Environ Health; 1987; 22(1):63-78. PubMed ID: 3612836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of different oral doses of isoniazid-rifampicin in rats.
    Rana SV; Pal R; Vaiphie K; Singh K
    Mol Cell Biochem; 2006 Sep; 289(1-2):39-47. PubMed ID: 16583132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of azosemide and furosemide in ascitic patients without and during administration of spironolactone.
    Radó JP; Molnár Z; Hartai A; Gercsák G
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):532-7. PubMed ID: 7174156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2 protects against furosemide-induced hepatotoxicity.
    Qu Q; Liu J; Zhou HH; Klaassen CD
    Toxicology; 2014 Oct; 324():35-42. PubMed ID: 24813929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a hepatoprotective agent, YH-439, on the pharmacokinetics of furosemide and azosemide in rats.
    Kim SH; Park KJ; Yoon WH; Lee JW; Kim ND; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Feb; 91(2):233-44. PubMed ID: 8832915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of neurohumoral effects of short-acting and long-acting loop diuretics in patients with chronic congestive heart failure.
    Tsutsui T; Tsutamoto T; Maeda K; Kinoshita M
    J Cardiovasc Pharmacol; 2001 Oct; 38 Suppl 1():S81-5. PubMed ID: 11811366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of hepatotoxicity and the target tissue dose of decabrominated diphenyl ether in subacutely exposed Wistar rats.
    Ćurčić M; Tanasković S; Stanković S; Janković S; Antunović M; Djordjević S; Kilibarda V; Vučnić S; Antonijević B
    Vojnosanit Pregl; 2015 May; 72(5):405-13. PubMed ID: 26165047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective evaluation of serum ornithine carbamyltransferase activity as an index of hepatotoxicity in toxicological studies with rats.
    Bondy GS; Armstrong CL; Curran IH; Barker MG; Mehta R
    Toxicol Lett; 2000 Apr; 114(1-3):163-71. PubMed ID: 10713481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatotoxicity of gardenia yellow color in rats.
    Yamano T; Tsujimoto Y; Noda T; Shimizu M; Ohmori M; Morita S; Yamada A
    Toxicol Lett; 1988 Nov; 44(1-2):177-82. PubMed ID: 3188076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of hepato- and nephrotoxicity induced by antifungal drug voriconazole in laboratory rats.
    Somchit N; Chung JH; Yaacob A; Ahmad Z; Zakaria ZA; Kadir AA
    Drug Chem Toxicol; 2012 Jul; 35(3):304-9. PubMed ID: 22288423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver and gastrointestinal first-pass effects of azosemide in rats.
    Kim J; Kim SH; Lee MG
    J Pharm Pharmacol; 1997 Sep; 49(9):878-83. PubMed ID: 9306255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum enzyme activities and hepatic triglyceride levels in acute and subacute acetaminophen-treated rats.
    Buttar HS; Nera EA; Downie RH
    Toxicology; 1976 Jun; 6(1):9-20. PubMed ID: 941168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 1 study of azosemide (SK-110): single- and multiple-dose study.
    Kuzuya F
    Int J Clin Pharmacol Ther Toxicol; 1983 Jan; 21(1):10-23. PubMed ID: 6832863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitigation of hepatotoxic effects of arsenic trioxide through omega-3 fatty acid in rats.
    Mathews VV; Paul MS; Abhilash M; Manju A; Abhilash S; Nair RH
    Toxicol Ind Health; 2014 Oct; 30(9):806-13. PubMed ID: 23081861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between glucuronide conjugate levels and hepatotoxicity after oral administration of valproic acid.
    Lee MS; Lee YJ; Kim BJ; Shin KJ; Chung BC; Baek DJ; Jung BH
    Arch Pharm Res; 2009 Jul; 32(7):1029-35. PubMed ID: 19641884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of gender on cocaine hepatotoxicity in CF-1 mice.
    Visalli T; Turkall R; Abdel-Rahman MS
    Int J Toxicol; 2005; 24(1):43-50. PubMed ID: 15981739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.